Benitec Biopharma INC. (BNTC) — 8-K Filings

All 8-K filings from Benitec Biopharma INC.. Browse 24 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (24)

Benitec Biopharma Files 8-K on Shareholder Votes — Dec 2, 2025 Risk: low
Benitec Biopharma Inc. filed an 8-K on December 2, 2025, reporting on matters submitted to a vote of security holders as of December 1, 2025. The filing details
8-K Filing — Nov 7, 2025
Benitec Biopharma Reports Director/Officer Changes & More — Nov 3, 2025 Risk: medium
Benitec Biopharma Inc. filed an 8-K on November 3, 2025, reporting events as of November 2, 2025. The filing indicates changes related to directors and officers
Benitec Biopharma Restates Financials — Sep 12, 2025 Risk: high
Benitec Biopharma Inc. announced on September 10, 2025, that it will not rely on previously issued financial statements or related audit reports. This decision
Benitec Biopharma Files 8-K Report — Jul 9, 2025 Risk: low
On July 9, 2025, Benitec Biopharma Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, and a Regulation FD disclosure. No
Benitec Biopharma Files 8-K — Mar 28, 2025 Risk: medium
On March 26, 2025, Benitec Biopharma Inc. filed an 8-K report. The filing indicates an 'Other Event' without specifying further details in the provided text. Th
Benitec Biopharma Enters Material Definitive Agreement — Mar 27, 2025 Risk: medium
On March 26, 2025, Benitec Biopharma Inc. entered into a material definitive agreement. The company, incorporated in Delaware with its principal executive offic
Benitec Biopharma Files 8-K: Material Agreement & Financials — Mar 26, 2025 Risk: medium
On March 25, 2025, Benitec Biopharma Inc. entered into a material definitive agreement. The company also reported on other events and filed financial statements
Benitec Biopharma Files 8-K for Other Events — Mar 20, 2025 Risk: medium
On March 20, 2025, Benitec Biopharma Inc. filed an 8-K report. The filing indicates that the company is providing information under "Other Events." Specific det
Benitec Biopharma Files 8-K — Mar 19, 2025 Risk: low
On March 19, 2025, Benitec Biopharma Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No
Benitec Biopharma Reports Director Changes and Officer Compensation Updates — Dec 13, 2024 Risk: medium
On December 9, 2024, Benitec Biopharma Inc. reported a change in its board of directors and executive compensation arrangements. The filing indicates a departur
Benitec Biopharma Files 8-K on Security Holder Rights — Dec 10, 2024 Risk: medium
On December 9, 2024, Benitec Biopharma Inc. filed an 8-K report detailing material modifications to security holder rights and amendments to its articles of inc
Benitec Biopharma Reports on Shareholder Vote — Dec 6, 2024 Risk: low
Benitec Biopharma Inc. filed an 8-K on December 6, 2024, reporting on a matter submitted to a vote of its security holders on December 4, 2024. The filing detai
Benitec Biopharma Files Current Report — Oct 15, 2024 Risk: low
Benitec Biopharma Inc. filed an 8-K on October 15, 2024, reporting an event on October 12, 2024. The filing is a current report pursuant to Section 13 or 15(d)
Benitec Biopharma Files 8-K: Material Agreement & Financials — Oct 11, 2024 Risk: medium
On October 11, 2024, Benitec Biopharma Inc. filed an 8-K report. The filing indicates the company entered into a Material Definitive Agreement and also includes
Benitec Biopharma Files 8-K with Financials — Oct 8, 2024 Risk: low
On October 8, 2024, Benitec Biopharma Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, indicating potential updates or
Benitec Biopharma Files 8-K for Operations Update — Sep 26, 2024 Risk: low
Benitec Biopharma Inc. filed an 8-K on September 26, 2024, to report on its results of operations and financial condition, as well as to file financial statemen
Benitec Biopharma Reports Director Changes and Shareholder Votes — Sep 5, 2024 Risk: medium
Benitec Biopharma Inc. filed an 8-K on August 29, 2024, reporting on the departure of directors, election of new directors, and compensatory arrangements. The f
Benitec Biopharma Files 8-K Report — Jul 15, 2024 Risk: low
On July 15, 2024, Benitec Biopharma Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and the filing of Financial Statements and
Benitec Biopharma Announces Director Changes and Officer Compensation Updates — Jul 1, 2024 Risk: medium
On June 26, 2024, Benitec Biopharma Inc. filed an 8-K report detailing the departure of Director Dr. David J. Wood and the appointment of Dr. Christopher P. De
Benitec Biopharma Files 8-K: Material Agreement & Equity Sales — Apr 19, 2024 Risk: medium
On April 17, 2024, Benitec Biopharma Inc. entered into a Material Definitive Agreement, the details of which are not fully disclosed in this filing. The company
Benitec Biopharma Files 8-K Report — Apr 18, 2024 Risk: low
On April 18, 2024, Benitec Biopharma Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, and includes a Regulation FD Dis
Benitec Biopharma Appoints New CMO, Adds Directors — Mar 8, 2024 Risk: medium
Benitec Biopharma Inc. announced on March 6, 2024, the appointment of Dr. Joseph S. Carillo as Chief Medical Officer and the election of Ms. Jennifer L. D. Alli
Benitec Biopharma Files 8-K for Financial Results — Feb 13, 2024 Risk: medium
Benitec Biopharma Inc. filed an 8-K on February 13, 2024, to report its results of operations and financial condition. The filing also includes financial statem

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX